As a result, TGFB1 can promote targeted migration of breast cancer cells through the lymphatic system [77], inhibit lymphatic growth and promote vascular angiogenesis [78], or contribute to resistance in endocrine-related cancers [79]. This evidence concerns the gene TGFB1 and breast carcinoma.